By Wholesale Investor
In the high-octane world of biotechnology, success is often measured by the narrowest of margins. But for Dr. Ian Nisbet, CEO of Melbourne-based Cartherics Pty Ltd, the mission is defined by a gap so large it has become a “tragic” outlier in modern medicine: the chronic underfunding of women’s health.
Ovarian cancer, often called […]
Cartherics is pleased to share Dr Ian Nisbet’s presentation at the Emergence Investment Conference in Sydney, where he outlined the Company’s strategy, progress and vision for transforming women’s health through pioneering cellular immunotherapies.
Speaking to an audience of investors and industry leaders, Dr Nisbet highlighted Cartherics’ unique focus on developing off-the-shelf cell therapies designed specifically to […]
Melbourne, Australia, 16 December 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead […]
Melbourne, Australia, 4 December 2025 – An exciting chapter in medical innovation begins today with the official launch of Evinco Therapeutics Pty Ltd (“Evinco” or “Company”), a Melbourne-based biotechnology company developing advanced immune-based therapies for […]
Melbourne, Australia, 28 November 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian […]
Melbourne, Australia, 6 August 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune stem cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, today unveiled its new, state-of-the-art cleanroom facility for clinical-scale manufacturing of cell therapy products.
The facility was officially opened by the […]
Melbourne, Australia, 28 May 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company focused on developing immune cell therapies for cancer and other diseases, announced today that Dr. Ian Nisbet, […]
Melbourne, Australia, 16 April 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company focused on developing immune cell therapies for cancer and other diseases, is pleased to announce the appointment of Prof. Bryan R.G. Williams […]
Melbourne, Australia, 18 December 2024 – Cartherics Pty Ltd (“Cartherics” or “Company”), […]
Melbourne, Australia, 1 October 2024 – Cartherics Pty Ltd (“Cartherics” or “Company”), a […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer and endometriosis.
Stay informed about our latest news and developments
© Copyright 2022 – 2026| Cartherics Pty Ltd
